Cytokine effect on ex vivo expansion of haemopoietic stem cells from different human sources

被引:29
作者
Eridani, S [1 ]
Mazza, U
Massaro, P
La Targia, ML
Maiolo, AT
Mosca, A
机构
[1] CNR, Ist Tecnol Biomed Avanzate, Cell Culture Lab, I-20131 Milan, Italy
[2] Univ Milan, Inst Clin Chem, I-20122 Milan, Italy
[3] Univ Milan, Inst Haematol, I-20122 Milan, Italy
关键词
bone marrow; peripheral blood; cord blood; ex vivo expansion; haemopoietic stem cells;
D O I
10.1007/BF02678549
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Human pluripotential stem cells (PSC) are currently the target for transplantation attempts and genetic manipulation. We have therefore investigated the frequency and the expansion potential of PSC's in different types of blood samples. CD 34(+) cells were thus obtained from human bone marrow (BM), as well as from peripheral blood (PB) and cord blood (CB) samples. After immune-magnetic separation the highest yields of CD 34(+) cells were from BM (1.08-2.25%) and CB (0.42-1.32%) while PB samples gave much lower values. Suspension cultures of PSC's from the three sources were then set up, in the presence of combinations of haemopoietic growth factors. A remarkable amplification of the nucleated cell pool was observed reaching a maximum between 10 and 15 days of culture; earliest and maximum expansion (up to 220-fold) was achieved when Erythropoietin (Epo) was added to the culture medium, but this resulted in reduction of colony-forming cells and differentiation into erythroid progenitors. Clonogenic tests for BFU-E's derived colonies showed a peak value at 5 days of liquid culture. Further studies are advisable to establish the best cytokine combination for a valuable ex vivo expansion, coupled with preservation of stem cell properties.
引用
收藏
页码:295 / 298
页数:4
相关论文
共 16 条
[1]
ISOLATION OF A CANDIDATE HUMAN HEMATOPOIETIC STEM-CELL POPULATION [J].
BAUM, CM ;
WEISSMAN, IL ;
TSUKAMOTO, AS ;
BUCKLE, AM ;
PEAULT, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :2804-2808
[2]
BERTOLINI F, 1995, BONE MARROW TRANSPL, V15, P159
[3]
Highly purified CD34-positive cells reconstitute hematopoiesis [J].
Civin, CI ;
Trischmann, T ;
Kadan, NS ;
Davis, J ;
Noga, S ;
Cohen, K ;
Duffy, B ;
Groenewegen, I ;
Wiley, J ;
Law, P ;
Hardwick, A ;
Oldham, F ;
Gee, A .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) :2224-2233
[4]
Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics [J].
Emerson, SG .
BLOOD, 1996, 87 (08) :3082-3088
[5]
IDENTIFICATION OF HEMATOPOIETIC STEM-CELLS [J].
ERIDANI, S ;
MORALI, F .
CYTOTECHNOLOGY, 1993, 11 (02) :101-106
[6]
Fritsch G, 1996, BONE MARROW TRANSPL, V17, P169
[7]
Lange W, 1996, LEUKEMIA, V10, P943
[8]
HIGH-GRADIENT MAGNETIC CELL-SEPARATION WITH MACS [J].
MILTENYI, S ;
MULLER, W ;
WEICHEL, W ;
RADBRUCH, A .
CYTOMETRY, 1990, 11 (02) :231-238
[9]
OGAWA M, 1993, BLOOD, V81, P2844
[10]
Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor [J].
Schwarzenberger, P ;
Spence, SE ;
Gooya, JM ;
Michiel, D ;
Curiel, DT ;
Ruscetti, FW ;
Keller, JR .
BLOOD, 1996, 87 (02) :472-478